Intratumoral Heterogeneity in a Patient With Metastatic Thymic Carcinoma on 18F-FDG, 68Ga-DOTATATE, and 68Ga-FAPI04 PET/CT.

Isik, Emine Göknur; Kuyumcu, Serkan; Ozkan, Zeynep Gözde; Has Simsek, Duygu; Sanli, Yasemin

Isik, Emine Göknur; Kuyumcu, Serkan; Ozkan, Zeynep Gözde; Has Simsek, Duygu; Sanli, Yasemin.

Isik EG; From the Department of Nuclear Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Clin Nucl Med ; 47(1): e79-e80, 2022 Jan 01.

Article en En | MEDLINE | ID: mdl-34392280

RESUMEN

ABSTRACT: Herein, we present a 72-year-old woman with metastatic thymic carcinoma, referred for salvage peptide receptor radionuclide therapy with 177Lu-DOTATATE after completing all treatment options according to current clinical practice and guidelines. However, the patient was not eligible for 177Lu-DOTATATE peptide receptor radionuclide therapy and underwent 68Ga-FAPI04 PET/CT to assess the potential for a FAP-targeted therapy.

Asunto(s)

Compuestos Organometálicos; Timoma; Neoplasias del Timo; Anciano; Femenino; Fluorodesoxiglucosa F18; Humanos; Tomografía Computarizada por Tomografía de Emisión de Positrones; Tomografía de Emisión de Positrones; Cintigrafía; Neoplasias del Timo/diagnóstico por imagen

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Compuestos Organometálicos / Timoma / Neoplasias del Timo Tipo de estudio: Guideline Límite: Aged / Female / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google